CONMED (CNMD) stock price, chart and financials

Price chart

Revenue (trailing twelve months)

$1.4B

Revenue (quarter)

$343.5M

Revenue growth (year over year)

+0.33%

Gross profit (trailing twelve months)

$765.3M

Gross margin

55.79%

Net income (trailing twelve months)

$56.5M

Net income (quarter)

$23.1M

Net income growth (year over year)

+7.70%

Net margin

4.12%

Return on equity

5.53%

EPS (trailing twelve months)

$1.85

Book value per share

$34.73

P/E (trailing twelve months)

24.15

Price to book

1.31

Debt to assets

54.73%

Payout ratio

39.44%

Dividend yield

0.45%

Company profile

Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.

• Is CONMED (CNMD) profitable?

  Yes. CONMED earned $56.5M in net income over the trailing twelve months, a net margin of 4.12%.

• How much revenue does CONMED (CNMD) make?

  CONMED generated $1.4B in revenue over the trailing twelve months, up 0.33% year over year.

• What is CNMD's P/E ratio?

  CONMED trades at 24.1 times trailing twelve-month earnings, on an EPS of $1.85.

• How do I buy stock in CONMED (CNMD)?

  CNMD trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at Light Horse Dashboard, the trading API, or an AI agent connected over MCP. The trade panel on this page places the order once you are signed in.